Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 13 Aug, 01:00 am
Strong Earnings Performance: Brinker International (NYSE:EAT) reported an earnings per share (EPS) of $3.07 , matching estimates and significantly up from $2.49 year-over-year. Revenue Growth Driven by Chili's: The casual dining giant achieved $1.52 billion in revenue , an increa
Lenz Therapeutics (NASDAQ:LENZ) is actively progressing the commercial launch of VIZZ, its innovative presbyopia treatment, with new marketing strategies and telehealth options driving increased prescriptions. Investment firm Piper Sandler adjusted its price target for Lenz Thera
Oppenheimer reaffirmed its "Outperform" rating for Middleby, highlighting confidence in the company's future. Middleby completed a strategic business transformation, divesting non-core assets to focus entirely on the commercial foodservice industry. The company reported strong Q2
RADCOM Ltd. (NASDAQ:RDCM) reported a Q2 2026 EPS of -$0.09 , missing the $0.24 estimate, with revenue at $11.76 million , a 33.4% decrease, primarily due to deployment delays. Despite the quarterly miss, RADCOM secured three new contracts and announced a $20 million to $25 millio
Merck & Co., Inc. (NYSE:MRK) received an "Outperform" rating and a $143.00 price target from Daiwa, indicating a 9.62% potential upside. The pharmaceutical giant reported robust Q2 2026 revenue of $16.6 billion , a 5% increase, driven by strong KEYTRUDA sales of $8.4 billion . Si
Analyst firm Piper Sandler increased its price target for Corebridge Financial, reflecting confidence in its future performance and maintaining an "Overweight" rating. Corebridge Financial reported strong second-quarter earnings of $1.12 per share , surpassing estimates, and is n
Amcor plc (NYSE: AMCR) Beats Q4 2026 Estimates as Berry Acquisition Drives Sales Growth Amcor plc (NYSE: AMCR) reported adjusted diluted EPS of $1.23 , exceeding the analyst estimate of $1.19. Fiscal fourth-quarter net sales increased 26% to $6.40 billion , surpassing the consens
Analyst firm Jefferies adjusted its price target for Quantinuum (QNT) to $85.00 , suggesting a potential upside of approximately 51.62% from its trading price. Quantinuum (QNT) reported robust financial performance with $8.00 million in revenue, marking a 279% year-over-year incr
Teva Pharmaceutical Industries is undergoing a significant strategic shift, moving from traditional generic drugs to a focus on specialty and innovative medicines. Analyst firm Barclays has issued an "Overweight" rating and raised its price target for Teva , reflecting strong con
Novo Nordisk faces a "Sell" rating due to increasing competitive pressures and internal operational challenges. An analyst has set a cautious price target of $47.00 for Novo Nordisk , reflecting concerns despite its leadership in the GLP-1 market . Intense competition from Eli Li
Okta maintains a dominant 41% share in the independent Identity and Access Management (IAM) market. The company has received significant analyst upgrades, including an "Outperform" rating from Citigroup and an average "Strong Buy" recommendation from 43 brokerage firms. Financial
Entegris (NASDAQ: ENTG) received an upgrade from Deutsche Bank to "Buy," signaling positive future performance. The company reported strong Q2 2026 results, with non-GAAP earnings of $0.93 per share and net sales of $883.20 million , both exceeding analyst expectations. Growth wa
Velo3D Inc. (NASDAQ: VELO) reported strong Q2 revenue of $20.66 million , significantly exceeding analyst estimates of $14.15 million , marking a 52.3% year-over-year increase. Despite robust revenue growth, the company posted an earnings per share (EPS) of -$0.30 , missing the c
Beyond Meat (NASDAQ: BYND) Announces 1-for-30 Reverse Stock Split Amid Nasdaq Delisting Risk Beyond Meat is restructuring its business, focusing on core markets and completing the wind-down of its operations in China as it seeks to improve profitability. The company received a Na
QuickLogic Corporation (NASDAQ: QUIK) Q2 Earnings Miss Estimates Despite Strong Revenue Growth QuickLogic Corporation reported a quarterly loss of $0.06 per share and revenue of $5.48 million , both missing analyst estimates for Q2 2026. Despite missing targets, revenue increased
Spectral AI's Q2 earnings reported an EPS of -$0.13 , slightly beating estimates, but revenue of $3.52 million missed expectations as the company transitions to commercial operations. The company is focused on building its commercial infrastructure for the DeepView System followi
Despite a lowered analyst price target, CAVA (NYSE: CAVA) demonstrates significant growth potential. The fast-casual Mediterranean restaurant chain reported strong Q2 2026 financial results, surpassing earnings and revenue estimates. CAVA continues its strategic expansion, openin
Integra Resources Corp. (AMEX:ITRG) reported a Q2 EPS of $0.06 , missing analyst estimates, but demonstrated strong operational improvements including a 30% increase in gold production . Despite missing revenue estimates at $70.80 million , the company achieved significant year-o
Headlines provided by Investing.com